1. Home
  2. JPC vs LIVN Comparison

JPC vs LIVN Comparison

Compare JPC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JPC
  • LIVN
  • Stock Information
  • Founded
  • JPC 2003
  • LIVN 1987
  • Country
  • JPC United States
  • LIVN United Kingdom
  • Employees
  • JPC N/A
  • LIVN N/A
  • Industry
  • JPC Investment Managers
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • JPC Finance
  • LIVN Health Care
  • Exchange
  • JPC Nasdaq
  • LIVN Nasdaq
  • Market Cap
  • JPC 2.9B
  • LIVN 3.0B
  • IPO Year
  • JPC N/A
  • LIVN 1993
  • Fundamental
  • Price
  • JPC $8.15
  • LIVN $63.71
  • Analyst Decision
  • JPC
  • LIVN Strong Buy
  • Analyst Count
  • JPC 0
  • LIVN 7
  • Target Price
  • JPC N/A
  • LIVN $62.43
  • AVG Volume (30 Days)
  • JPC 998.5K
  • LIVN 682.0K
  • Earning Date
  • JPC 01-01-0001
  • LIVN 11-05-2025
  • Dividend Yield
  • JPC 7.57%
  • LIVN N/A
  • EPS Growth
  • JPC N/A
  • LIVN N/A
  • EPS
  • JPC N/A
  • LIVN N/A
  • Revenue
  • JPC N/A
  • LIVN $1,348,962,000.00
  • Revenue This Year
  • JPC N/A
  • LIVN $10.10
  • Revenue Next Year
  • JPC N/A
  • LIVN $7.90
  • P/E Ratio
  • JPC N/A
  • LIVN N/A
  • Revenue Growth
  • JPC N/A
  • LIVN 8.63
  • 52 Week Low
  • JPC $5.94
  • LIVN $32.48
  • 52 Week High
  • JPC $7.36
  • LIVN $64.08
  • Technical
  • Relative Strength Index (RSI)
  • JPC 56.11
  • LIVN 73.86
  • Support Level
  • JPC $7.84
  • LIVN $53.37
  • Resistance Level
  • JPC $8.09
  • LIVN $56.15
  • Average True Range (ATR)
  • JPC 0.07
  • LIVN 2.24
  • MACD
  • JPC 0.00
  • LIVN 1.15
  • Stochastic Oscillator
  • JPC 92.42
  • LIVN 97.21

About JPC Nuveen Preferred & Income Opportunities Fund

Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its primary investment objective is to provide high current income, and its secondary investment objective is total return. The fund invests a majority of its assets in preferred securities and other income-producing securities, including hybrid securities such as contingent capital securities, and the rest of its investments are made in other securities, mainly income-oriented securities such as corporate and taxable municipal debt and common equity.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: